SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000886163-24-000020
Filing Date
2024-04-25
Accepted
2024-04-24 19:30:39
Documents
24
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A lngd-20240424.htm   iXBRL DEF 14A 1322349
6 lngd-20240424_g1.gif GRAPHIC 9144
7 lngd-20240424_g10.jpg GRAPHIC 249614
8 lngd-20240424_g2.jpg GRAPHIC 101471
9 lngd-20240424_g3.gif GRAPHIC 43730
10 lngd-20240424_g4.gif GRAPHIC 11884
11 lngd-20240424_g5.jpg GRAPHIC 58200
12 lngd-20240424_g6.jpg GRAPHIC 92773
13 lngd-20240424_g7.jpg GRAPHIC 83622
14 lngd-20240424_g8.jpg GRAPHIC 64104
15 lngd-20240424_g9.jpg GRAPHIC 253008
  Complete submission text file 0000886163-24-000020.txt   4349492

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lngd-20240424.xsd EX-101.SCH 2457
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lngd-20240424_def.xml EX-101.DEF 2648
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lngd-20240424_lab.xml EX-101.LAB 2948
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lngd-20240424_pre.xml EX-101.PRE 1719
27 EXTRACTED XBRL INSTANCE DOCUMENT lngd-20240424_htm.xml XML 92887
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33093 | Film No.: 24872340
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)